
Company Info
Year Established2011
Contacts
David UrechCEO
Roland Helfenstein
CFO
Mireia Gomez-Angelats
CBO
Company Description
Numab is developing multi-specific antibody-based immunotherapies for inflammation and cancer. Reproducible plug-and-play therapeutic design process.
